Abstract:This study’s purpose is to develop a deep-learning-based approach to generate synthetic MRI (sMRI) for accurate online target delineation and localization and synthetic CT (sCT) for accurate dose calculation during CBCT-guided adaptive prostate cancer radiotherapy (RT). We propose to integrate dense blocks into a 3D cycle-generative adversarial network (cycle-GAN) framework to generate sMRI from daily CBCT, and incorporate residual block minimization into a 3D cycle-GAN framework to generate sCT from daily CBCT. Our networks can automatically learn the transformations from the daily CBCT to the sMRI/sCT through the training CBCT-MRI and CBCT-CT pairs. In addition, the cycle-GANs improve the learning outcomes by incorporating inverse transformations such that the cycle-CBCTs are produced from the sMRI and sCT. To generate synthetic/cycle images similar to the real training datasets, both transformations are implemented by a generator network and their outputs are judged by a discriminator. Training the generator takes into account of the discriminator feedback as well as the estimation errors between the synthetic and real/cycle and real ones. A supervised U-Net has been proposed to segment the prostate from the sMRI generated from daily CBCT. The original MRI-defined prostate was deformed to sMRI assess the prostate segmentation accuracy. Our sCT and CBCT were registered to planning CT (pCT) for generating sCT-based and CBCT-based treatment plans. Mean absolute error (MAE) and normalized cross-correlation (NCC) were used to quantify the differences between the sCT and pCT. Clinically-relevant dose volume histogram (DVH) metrics were extracted from sCT-based and CT-based treatment plans for quantitative dosimetric evaluation. The proposed adaptive RT procedure was tested using 20 prostate cancer patients with 36 treatment plans (mean prescription dose: 45±14 Gy), each of whom has CBCT, MRI and pCT. The mean volume Dice Overlap Coefficient was 89.8±5.5% between our sMRI-based U-net segmented and MRI-defined prostate. The mean MAE and NCC between sCT and pCT were 16.9±5.6 HU and 0.98±0.02. The mean prostate dose differences between sCT- and pCT-based plans were 0.11±0.68%, 0.09±0.41%, 0.04±0.38%, 0.04±0.34%, 0.05±0.38%, and 0.46±1.03% for Dmin, D10, D50, D95, Dmean, and Dmax, respectively. The mean bladder, rectum and femur head dose differences between sCT- and CT-based plans ranged from -0.22% to 0.85% for all DVH metrics. We have developed deep-learning-based methods to generate sMRI and sCT from daily CBCT. This study demonstrated that the proposed methods are capable of reliably improving target delineation and providing comparable dose accuracy to the pCT for prostate cancer treatment planning. The accurate sMRI-based prostate delineation and localization as well as precise sCT-based dose calculation warrants further development of a CBCT-guided adaptive RT workflow for prostate cancer.

Future mainstream platform for online adaptive radiotherapy will be using on‐board MR rather than on‐board (CB) CT images

Personalizing radiotherapy with adaptive radiotherapy: Interest and challenges

Technical Challenges of Real-Time Adaptive MR-Guided Radiotherapy

Adaptive Radiotherapy: Next-Generation Radiotherapy

Key technologies and challenges in online adaptive radiotherapy for lung cancer

Registration of On-Board X-ray Images with 4DCT: A Proposed Method of Phase and Setup Verification for Gated Radiotherapy

A Preliminary Simulation Study of Dose-Guided Adaptive Radiotherapy Based on Halcyon MV Cone-Beam CT Images With Retrospective Data From a Phase II Clinical Trial

Prospects for daily online adaptive radiotherapy via ethos for prostate cancer patients without nodal involvement using unedited CBCT auto‐segmentation

The feasibility of CT simulation‐free adaptive radiation therapy

Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance

Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer

Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT)

Future of Multidisciplinary Team in the Context of Adaptive Therapy

Cbct-Guided Prostate Adaptive Radiotherapy With Cbct-Based Synthetic Mri And Ct

Enhancing Precision in Radiation Therapy for Locally Advanced Lung Cancer: A Case Study of Cone-Beam Computed Tomography (CBCT)-Based Online Adaptive Techniques and the Promise of HyperSight™ Iterative CBCT

Adaptive-Driven CT Simulation-Free Soft Tissue Stereotactic Body Radiation Therapy: A Single-Patient Case Report

Adaptive assessment based on fractional CBCT images for cervical cancer

A Retrospective Study on the Investigation of Potential Clinical Benefits of Online Adaptive Proton Therapy for Head and Neck Cancer

Initial Experience of CT-Based Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma With a Novel Integrated Platform: A Case Report

Safety and Efficiency Analysis of Operational Decision-Making During CBCT-Based Online Adaptive Radiotherapy

Solution for the External Contour Changes in Cone Beam Computed Tomography-Guided On-demand Online Adaptive Radiotherapy for a Patient With Very Advanced Head and Neck Cancer: A Technical Case Report